A deadly outbreak of the Bundibugyo species of Ebola in the Democratic Republic of the Congo is being tackled by Oxford University scientists who are in the process of developing a vaccine using the same technology that underpinned its Covid-19 jab. While there is no proven jab for this species of Ebola, there is an Ebola vaccine for the Zaire species but not for the Bundibugyo strain.
Oxford University scientists are developing an Ebola vaccine that could help tackle a deadly outbreak of the disease within months. The rare species of Ebola currently spreading in the Democratic Republic of the Congo - known as Bundibugyo - kills 30 to 50 percent of those infected but there is no proven jab.
The outbreak has resulted in 750 suspected cases and 177 deaths. The Oxford Vaccine Group (OVG) is now using the same technology that underpinned its Covid-19 jab to develop one specific to Bundibugyo. The species has caused two previous outbreaks, one in Uganda in 2007 and one in the Democratic Republic of the Congo in 2012. The risk of the current outbreak in the DRC is now considered to be very high, with suspected cases tripling in a week.
The reassignment comes after the UN health agency declared a public health emergency of international concern and stressed that the outbreak is not a pandemic
Ebola Vaccine Bundibugyo Democratic Republic Of The Congo Covid-19 Jab Oxford Vaccine Group Common Cold Virus Chadox1 Animal Research Clinical Tria Serum Institute Of India
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
No Ebola vaccines exist for the strain in the current outbreak, but scientists are developing someA decade after Ebola vaccines changed outbreak response, a new epidemic in central Africa is caused by a strain the world never fully prepared for
Read more »
Rapid Ebola Outbreak: WHO Official Worries About Scale and SpeedThe latest outbreak involves the Ebola strain Bundibugyo virus disease (BVD), which has no approved vaccine or treatment. Health officials and aid workers in the Democratic Republic of Congo (DRC) are raising concerns about the undetected spread of the disease because officials were testing for the more common strain of Ebola and the results were repeatedly negative.
Read more »
Oxford Scientists Developing Ebola Vaccine to Combat Deadly OutbreakOxford University scientists are working on a vaccine for the Bundibugyo strain of Ebola, which caused two previous outbreaks in Uganda and the Democratic Republic of the Congo. The vaccine uses the same technology as the Covid-19 jab and hopes to be available in two to three months if needed.
Read more »
The rare Ebola virus behind the current outbreak, explainedBundibugyo virus is an uncommon species of Ebola-causing virus that has been linked to only two other known outbreaks
Read more »